Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment
Giulio Bonomo, Giuseppe Barbagallo(University of Catania), Alessandro Pluchino(University of Catania), Antonella Agodi(University of Catania), Davide Barbagallo(University of Catania), Corrado Spatola(University of Catania), Héctor Soto Parrà, Andrea Maugeri, Giovanni Buscema(University of Catania), Giuseppe Broggi(University of Catania), Rosario Caltabiano(University of Catania), Giuseppa Fiumanò(Ospedale Santa Maria), Erica Grasso, Gaetano Magro(University of Catania), Fiorenza Latteri(University of Catania), Francesco Certo(University of Catania)
Cited by 2
Related Papers
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
|The Lancet|2024|3.3k
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Neurology|2024|1.9k
Global Burden of Cardiovascular Diseases and Risks, 1990-2022
|Journal of the American College of Cardiology|2023|1.5k